Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population
Authors:
- Metin BagliMBMetin Bagli
- Andreas PapassotiropoulosAPAndreas Papassotiropoulos
- Michael KnappMKMichael Knapp
- Frank JessenFJFrank Jessen
- Marie Luise RaoMRMarie Luise Rao
- Wolfgang MaierWMWolfgang Maier
- Reinhard HeunRHReinhard Heun
- 1 April 2000
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 283 (2) , 109-112
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.Journal of Clinical Investigation, 1998
- Longitudinal Study of Inflammatory Factors in Serum, Cerebrospinal Fluid, and Brain Tissue in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1998
- Physiological and pathological roles of interleukin-6 in the central nervous systemMolecular Neurobiology, 1997
- Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's diseaseNeuroscience Letters, 1997
- Transgenic models to assess the pathogenic actions of cytokines in the central nervous systemMolecular Psychiatry, 1997
- Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisalNeurobiology of Aging, 1996
- Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depressionJournal of Affective Disorders, 1995
- Anti-inflammatory drugs and Alzheimer diseaseThe Lancet, 1990
- Rapid detection and sequencing of alleles in the 3′ flanking region of the Interleukin-6 geneNucleic Acids Research, 1989
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984